Principal investigator
Tom Hodgkinson
Principal Investigator
Bone and joint repair · Biomaterials · Gene delivery · Drug delivery
About
Research profile
Tom Hodgkinson develops regenerative biomaterials and gene-delivery approaches for musculoskeletal repair, with interests spanning stem-cell control, inflammation and chronic disease.
Expertise
Research interests
Lab members
Tom’s research team
No lab members are currently listed.
Current work
Research projects
Biomaterial scaffolds
Natural-polymer scaffolds engineered to reproduce extracellular-matrix structure, guide cell behaviour and support tissue repair.
7 associated researchers
Explore research areaHydrogels
Injectable, printable and stimuli-responsive hydrogels for controlled delivery, tissue support and next-generation biomedical devices.
6 associated researchers
Explore research areaBiofabrication and 3D printing
Additive-manufacturing and bioprinting approaches that organise biomaterials, cells and conductive components with spatial precision.
5 associated researchers
Explore research areaTargeted therapeutic delivery
Local delivery of drugs, proteins, peptides, bioinorganic ions, nucleic acids and cells from biomaterials and medical devices.
7 associated researchers
Explore research areaGene-activated materials
Non-viral vectors and biomaterial platforms that deliver genes, microRNAs and other nucleic-acid therapeutics at the site of repair.
6 associated researchers
Explore research areaAntimicrobial and immunomodulatory materials
Bioactive materials designed to counter infection, regulate inflammation and create a repair-supportive immune environment.
6 associated researchers
Explore research areaBone, cartilage, joint repair and PTOA
Regenerative and drug-delivery strategies for bone defects, cartilage damage, osteoarthritis and post-traumatic osteoarthritis (PTOA).
5 associated researchers
Explore research areaSelected outputs
Highlighted publications
A biomimetic reinforced type I/II collagen and hyaluronic acid scaffold in combination with a chondral biomaterial fixation technique for large articular cartilage defect repair: A pilot pre-clinical study.
Hyaluronic acid as a versatile building block for the development of biofunctional hydrogels: In vitro models and preclinical innovations.
An injectable and 3D printable pro-chondrogenic hyaluronic acid and collagen type II composite hydrogel for the repair of articular cartilage defects
Mechanosignalling in cartilage: an emerging target for the treatment of osteoarthritis.
The role of mechanobiology in bone and cartilage model systems in characterizing initiation and progression of osteoarthritis.
Highly Porous Type II Collagen-Containing Scaffolds for Enhanced Cartilage Repair with Reduced Hypertrophic Cartilage Formation.
Industry & translation
Turning research into impact.
TERG works with academic, clinical and industry partners to move biomaterials, devices and regenerative technologies towards patient benefit.
Industry, spin-outs and collaborationContact
Start a conversation.
For research, collaboration and supervision enquiries, email tomhodgkinson@rcsi.com.
Lab contact details